Cargando…
A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia
BACKGROUND: Human T-Lymphotropic Virus type 1 (HTLV-1) is endemic among people of Melanesian descent in Papua New Guinea, Solomon Islands and Vanuatu, and in Indigenous populations from Central Australia. Molecular studies revealed that these Australo-Melanesian strains constitute the highly diverge...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245899/ https://www.ncbi.nlm.nih.gov/pubmed/28060812 http://dx.doi.org/10.1371/journal.pntd.0005278 |
_version_ | 1782496903001276416 |
---|---|
author | Cassar, Olivier Charavay, Françoise Touzain, Frédéric Jeannin, Patricia Grangeon, Jean-Paul Laumond, Sylvie Chungue, Eliane Martin, Paul M. V. Gessain, Antoine |
author_facet | Cassar, Olivier Charavay, Françoise Touzain, Frédéric Jeannin, Patricia Grangeon, Jean-Paul Laumond, Sylvie Chungue, Eliane Martin, Paul M. V. Gessain, Antoine |
author_sort | Cassar, Olivier |
collection | PubMed |
description | BACKGROUND: Human T-Lymphotropic Virus type 1 (HTLV-1) is endemic among people of Melanesian descent in Papua New Guinea, Solomon Islands and Vanuatu, and in Indigenous populations from Central Australia. Molecular studies revealed that these Australo-Melanesian strains constitute the highly divergent HTLV-1c subtype. New Caledonia is a French overseas territory located in the Southwest Pacific Ocean. HTLV-1 situation is poorly documented in New Caledonia and the molecular epidemiology of HTLV-1 infection remains unknown. OBJECTIVES: Studying 500 older adults Melanesian natives from New Caledonia, we aim to evaluate the HTLV-1 seroprevalence and to molecularly characterize HTLV-1 proviral strains. STUDY DESIGN: Plasma from 262 men and 238 females (age range: 60–96 years old, mean age: 70.5) were screened for anti-HTLV-1 antibodies by particle agglutination (PA) and indirect immunofluorescence assay (IFA). Serological confirmation was obtained using Western blot assay. DNAs were extracted from peripheral blood buffy coat of HTLV-1 seropositive individuals, and subjected to four series of PCR (LTR-gag; pro-pol; pol-env and tax-LTR). Primers were designed from highly common conserved regions of the major HTLV-1 subtypes to characterize the entire HTLV-1 proviral genome. RESULTS: Among 500 samples, 3 were PA and IFA positive. The overall seroprevalence was 0.6%. The DNA sample from 1 New Caledonian woman (NCP201) was found positive by PCR and the complete HTLV-1 proviral genome (9,033-bp) was obtained. The full-length HTLV-1 genomic sequence from a native woman from Vanuatu (EM5), obtained in the frame of our previous studies, was also characterized. Both sequences belonged to the HTLV-1c Australo-Melanesian subtype. The NCP201 strain exhibited 0.3% nucleotide divergence with the EM5 strain from Vanuatu. Furthermore, divergence reached 1.1% to 2.9% with the Solomon and Australian sequences respectively. Phylogenetic analyses on a 522-bp-long fragment of the gp21-env gene showed the existence of two major clades. The first is composed of strains from Papua New Guinea; the second includes strains from all neighboring archipelagos (Solomon, Vanuatu, New Caledonia), and Australia. Interestingly, this second clade itself is divided into two sub-clades: strains from Australia on one hand, and strains from Solomon Islands, Vanuatu and New Caledonia on the other hand. CONCLUSIONS: The HTLV-1 seroprevalence (0.6%) in the studied adult population from New Caledonia appears to be low. This seroprevalence is quite similar to the situation observed in Vanuatu and Solomon Islands. However it is very different to the one encountered in Central Australia. Taken together, these results demonstrated that Australo-Melanesia is endemic for HTLV-1 infection with a high diversity of HTLV-1c strains and a clear geographic clustering according to the island of origin of HTLV-1 infected persons. |
format | Online Article Text |
id | pubmed-5245899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-52458992017-02-17 A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia Cassar, Olivier Charavay, Françoise Touzain, Frédéric Jeannin, Patricia Grangeon, Jean-Paul Laumond, Sylvie Chungue, Eliane Martin, Paul M. V. Gessain, Antoine PLoS Negl Trop Dis Research Article BACKGROUND: Human T-Lymphotropic Virus type 1 (HTLV-1) is endemic among people of Melanesian descent in Papua New Guinea, Solomon Islands and Vanuatu, and in Indigenous populations from Central Australia. Molecular studies revealed that these Australo-Melanesian strains constitute the highly divergent HTLV-1c subtype. New Caledonia is a French overseas territory located in the Southwest Pacific Ocean. HTLV-1 situation is poorly documented in New Caledonia and the molecular epidemiology of HTLV-1 infection remains unknown. OBJECTIVES: Studying 500 older adults Melanesian natives from New Caledonia, we aim to evaluate the HTLV-1 seroprevalence and to molecularly characterize HTLV-1 proviral strains. STUDY DESIGN: Plasma from 262 men and 238 females (age range: 60–96 years old, mean age: 70.5) were screened for anti-HTLV-1 antibodies by particle agglutination (PA) and indirect immunofluorescence assay (IFA). Serological confirmation was obtained using Western blot assay. DNAs were extracted from peripheral blood buffy coat of HTLV-1 seropositive individuals, and subjected to four series of PCR (LTR-gag; pro-pol; pol-env and tax-LTR). Primers were designed from highly common conserved regions of the major HTLV-1 subtypes to characterize the entire HTLV-1 proviral genome. RESULTS: Among 500 samples, 3 were PA and IFA positive. The overall seroprevalence was 0.6%. The DNA sample from 1 New Caledonian woman (NCP201) was found positive by PCR and the complete HTLV-1 proviral genome (9,033-bp) was obtained. The full-length HTLV-1 genomic sequence from a native woman from Vanuatu (EM5), obtained in the frame of our previous studies, was also characterized. Both sequences belonged to the HTLV-1c Australo-Melanesian subtype. The NCP201 strain exhibited 0.3% nucleotide divergence with the EM5 strain from Vanuatu. Furthermore, divergence reached 1.1% to 2.9% with the Solomon and Australian sequences respectively. Phylogenetic analyses on a 522-bp-long fragment of the gp21-env gene showed the existence of two major clades. The first is composed of strains from Papua New Guinea; the second includes strains from all neighboring archipelagos (Solomon, Vanuatu, New Caledonia), and Australia. Interestingly, this second clade itself is divided into two sub-clades: strains from Australia on one hand, and strains from Solomon Islands, Vanuatu and New Caledonia on the other hand. CONCLUSIONS: The HTLV-1 seroprevalence (0.6%) in the studied adult population from New Caledonia appears to be low. This seroprevalence is quite similar to the situation observed in Vanuatu and Solomon Islands. However it is very different to the one encountered in Central Australia. Taken together, these results demonstrated that Australo-Melanesia is endemic for HTLV-1 infection with a high diversity of HTLV-1c strains and a clear geographic clustering according to the island of origin of HTLV-1 infected persons. Public Library of Science 2017-01-06 /pmc/articles/PMC5245899/ /pubmed/28060812 http://dx.doi.org/10.1371/journal.pntd.0005278 Text en © 2017 Cassar et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Cassar, Olivier Charavay, Françoise Touzain, Frédéric Jeannin, Patricia Grangeon, Jean-Paul Laumond, Sylvie Chungue, Eliane Martin, Paul M. V. Gessain, Antoine A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia |
title | A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia |
title_full | A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia |
title_fullStr | A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia |
title_full_unstemmed | A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia |
title_short | A Novel Human T-lymphotropic Virus Type 1c Molecular Variant in an Indigenous Individual from New Caledonia, Melanesia |
title_sort | novel human t-lymphotropic virus type 1c molecular variant in an indigenous individual from new caledonia, melanesia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5245899/ https://www.ncbi.nlm.nih.gov/pubmed/28060812 http://dx.doi.org/10.1371/journal.pntd.0005278 |
work_keys_str_mv | AT cassarolivier anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT charavayfrancoise anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT touzainfrederic anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT jeanninpatricia anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT grangeonjeanpaul anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT laumondsylvie anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT chungueeliane anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT martinpaulmv anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT gessainantoine anovelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT cassarolivier novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT charavayfrancoise novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT touzainfrederic novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT jeanninpatricia novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT grangeonjeanpaul novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT laumondsylvie novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT chungueeliane novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT martinpaulmv novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia AT gessainantoine novelhumantlymphotropicvirustype1cmolecularvariantinanindigenousindividualfromnewcaledoniamelanesia |